Monitor for actual sale execution on Form 4 filings. This is a routine director-level sale plan; no immediate read-through for the stock.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $42.60entry
- T+1 · 17h ago −2.18%α −0.27% · $41.67
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Director Jeffrey Finer filed a Form 144 notice of intent to sell 66,000 shares of Septerna common stock, with an estimated aggregate market value of approximately $3.2 million based on the filing date. The shares would be acquired through the exercise of stock options over the next three months. The sale represents about 0.14% of the company's $2.5B market cap and is a routine insider sale by a director, not an executive officer, with no unusual timing or catalyst noted.
Key Facts
- Reporting person: Jeffrey Finer, a Director and Officer (not CEO/CFO)
- Shares to be sold: 66,000 shares of common stock
- Estimated aggregate market value: $3,204,960
- Shares to be acquired via exercise of stock options over the next three months
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Sale intended to be executed on Nasdaq
- Filing date: November 12, 2026
- Prior Form 144 filed on August 11, 2026 (no details provided)
Financial Impact
Approximately $3.2M, or about 0.13% of the company's $2.5B market cap
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed
- Director-level sales carry less signal than CEO/CFO sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-011038 |
| Document: 0001950047-26-011038-index.html | 0001950047-26-011038 |
| Document: 0001950047-26-011038.txt | 0001950047-26-011038 |
Track record
25 reports on SEPN
7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $41.67 Now $41.67 −0.00% settles Nov 24
- Nov 16, 2026today 144 Neutral 2/10 Entry $41.67 Now $41.67 −0.00% settles Nov 24
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $41.67 −0.45% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers